Screener
Tyra Biosciences, Inc. TYRA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
FAQ
- What is Tyra Biosciences, Inc.'s EPS (diluted)?
- Tyra Biosciences, Inc. (TYRA) reported EPS (diluted) of -$0.64 in Q1 2026.
- How has Tyra Biosciences, Inc.'s EPS (diluted) changed year-over-year?
- Tyra Biosciences, Inc.'s EPS (diluted) decreased by 36.2% year-over-year, from -$0.47 to -$0.64.
- What is the long-term trend for Tyra Biosciences, Inc.'s EPS (diluted)?
- Over 3 years (2022 to 2025), Tyra Biosciences, Inc.'s EPS (diluted) has grown at a 14.9% compound annual growth rate (CAGR), from -$1.32 to -$2.00.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Tyra Biosciences, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude